Medication info
Hyutecan Tablet 16mg (Candesartan Cilexetil)

Hyutecan Tablet 16mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Hankook Hyutex Pharmaceutical Co., Ltd.
Appearance
Light yellow-pink tablets that are round with a biconvex shape on both sides
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201706149 · Approved 2017.07.24 · Insurance code 649103580

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This medication should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into consideration, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No dose adjustment is necessary.
Child dose
1. Essential hypertension 6) Pediatric patients: The safety and efficacy in adolescents and children aged 18 years or younger have not been established. 2. Heart failure 3) Pediatric patients: The safety and efficacy in adolescents and children aged 18 years or younger have not been established.

Ingredients

Manufacturer
Hankook Hyutex Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • left ventricular systolic dysfunction
  • reduced left ventricular ejection fraction
View approved original text

This medication helps control blood pressure in patients with essential hypertension and is also used in heart failure patients, especially those with reduced left ventricular systolic function. In cases of heart failure, it is prescribed as an alternative treatment either alongside ACE inhibitors or in patients for whom ACE inhibitors are not suitable. Therefore, it is effectively used for managing hypertension and heart failure.

How to take

Adult dose

This medication should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into consideration, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No dose adjustment is necessary.

Child dose

1. Essential hypertension 6) Pediatric patients: The safety and efficacy in adolescents and children aged 18 years or younger have not been established. 2. Heart failure 3) Pediatric patients: The safety and efficacy in adolescents and children aged 18 years or younger have not been established.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, hence if pregnancy is confirmed, discontinuation should occur immediately. Patients who are allergic to this medication, women who are pregnant or breastfeeding, patients with severe liver dysfunction, and patients with certain genetic metabolic disorders should not take this medication. Elderly patients, those with high blood potassium levels, patients with impaired liver or kidney function, and patients with heart valve diseases should exercise caution when using this medication. Side effects such as dizziness, back pain, and respiratory infections may occur, and in rare cases, serious blood disorders, liver dysfunction, or skin rashes may arise; immediate consultation with a doctor is essential if unusual symptoms appear. Since this medication may affect kidney function, patients with kidney impairment should regularly monitor kidney function and serum potassium levels through blood tests. When used in conjunction with other antihypertensives, diuretics, or potassium supplements, the risk of side effects may increase due to interactions, hence consultation with a physician or pharmacist is necessary. There is a risk of dizziness when driving or operating machinery, and caution is advised. In cases of overdose, symptoms such as low blood pressure, dizziness, and rapid heartbeat may be noticed, requiring immediate medical attention. It is safest for children, adolescents, and pregnant or breastfeeding women not to use this medication. This medication should be kept out of the reach of children, and it is essential to store it in its original packaging as transferring it to another container may affect its quality.

Side effects

  • Dizziness
  • low back pain
  • respiratory infection
  • upper respiratory tract infection
  • pharyngitis
  • rhinitis
  • weakness
  • fever
  • sensory disturbance
  • indigestion
Show 67 more
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • kidney function impairment
  • increased creatinine
  • increased urea
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • intestinal vascular edema
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • syncope
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbance
  • decreased libido
  • amnesia
  • anorexia
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Light yellow-pink tablets that are round with a biconvex shape on both sides

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.